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ABSTRACT 
 
Uterine Uptake of Diazepam and Quantification by Gas Chromatography/Mass 
Spectrometry 
 
Steven Scott Wolfe 
 
One of the difficulties in drug delivery is transporting the compound of interest to the 
target organ while minimizing exposure to the rest of the body.  Intravenous 
administration is effective in the delivery of drugs and results in high bioavailability 
leading to very rapid systemic distribution.  Oral dosing of drugs is the most popular 
route because of its ease of administration, but it is subject to first pass metabolism by the 
liver which can greatly reduce the bioavailability of the parent compound.  Patients 
undergoing hysterectomy were recruited for a study in which they were anesthetized and 
5 mg of diazepam in gel was applied directly to the cervix by a patented drug delivery 
device (CerviPrepTM) consisting of a modified plastic syringe with a rounded cup on the 
end.  The operation was then begun and blood samples were taken from a peripheral vein 
at 0, 5, 10, 15, and 30 minutes during drug administration.  Samples were also taken from 
the uterine vein and uterine capillary bed at 30-45 minutes during drug administration 
had begun.  Red blood cells were separated from plasma and the plasma was analyzed for 
the presence of diazepam using an assay based on gas chromatography/mass 
spectrometry using stable isotopically labeled internal standards.  In some of the patients, 
there was a measurable concentration of diazepam in uterine capillary blood following 
cervical administration, and some patients had greater than a ten-fold higher 
concentration in uterine blood than peripheral blood.  The studies serve as a starting point 
for the development of delivery systems for other drugs, especially toxic anti-cancer 
drugs, delivered directly through the cervix and to the uterus.  The results indicate that it 
is possible to deliver a drug locally to the cervix through a transdermal process and 
observe blood concentrations that are higher than those from peripheral blood.   
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 Chapter One 
Introduction 
Transdermal delivery of drugs is not a new concept.  Since the early 1980’s, adhesive 
patches containing drug reservoirs and semi-permeable membranes have been used to 
deliver drugs through the skin.  Scopolamine, nitroglycerine, clonidine, nicotine, 
estradiol, and testosterone have been administered by transdermal patch delivery systems 
(figure 1).  Transdermal delivery provides a slow and steady release of drugs into the 
bloodstream and avoids first pass metabolism by the liver [1]. 
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 Transdermal delivery of drugs when applied directly to the cervix is a relatively new 
concept.  A device has been patented (CerviPrepTM) that can be used in the delivery of 
drugs in a gel form and applied directly to the cervix (figures 2 and 3).  The device looks 
much like a syringe with a rounded cup on the tip to serve as a reservoir for the gel.  The 
cup is in close contact with the cervix while the plunger is depressed and the drug enters 
the reservoir.  KY JellyTM was chosen as the matrix because it would contain the drug 
and hold it in place until the more lipophilic cervical tissue absorbed the drug.  The drug 
is absorbed in a mechanism similar to when using a transdermal patch and the lipophilic 
drug diffuses through the skin.  In a study by Woolfson and coworkers, a bioadhesive 
patch containing 5-fluorouracil was applied to excised cervical tissue and penetration 
exceeded 10 mm below the surface when using liquid scintillation spectrometry for 
measurement [4].   
Choice of Model Compound 
Diazepam is a benzodiazepine and was chosen for this study because it is lipophilic, 
neutral, and generally well-accepted by most of the population.  The drug was used only 
to prove that absorption takes place by applying a drug in a gel form directly to the cervix 
and that a measurable quantity would be found in plasma samples from the uterine vein 
and uterine capillary.  The molecular weight of diazepam is 284 amu and the 2H5 -
diazepam weighs 289 amu.  Using electrospray adds one proton (H+) therefore the 
spectrum for the 2H5 -diazepam will have a base peak of 290 amu.  It is evident that 2H5 -
diazepam contains a chlorine atom by the presence of a peak 2 units greater (292) and 
one-third the height of the 290 base peak.  For quantification purposes, our GC/MS data 
was collected in selected ion monitoring (SIM) mode where the mass spectrometer was 
2 
 scanning for only a few ions and thus the sensitivity is increased.  On occasion, full-scan 
spectra were obtained and compared to a search library to verify that diazepam was our 
compound.  The most intense ions for diazepam are 256 (100%), 283 (96%), and 284 
(75%) (figure 4). 
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 Benzodiazepines (figure 5) are prescribed frequently as anxiolytics, sedative hypnotics, 
anticonvulsants, and muscle relaxants.  They have been used clinically for over 30 years 
and have recently gained attention as drugs of abuse and used to commit crimes by giving 
a victim a dose that causes them to blackout.  Forensic analysis of these drugs involves 
methods such as thin-layer chromatography (TLC), gas chromatography (GC), and high 
performance liquid chromatography (HPLC).  These methods identify compounds based 
on their retention times.  Problems arise when two or more compounds elute at the same 
time and their peaks overlap.  More recently, methods have been developed using gas 
chromatography/mass spectrometry (GC/MS) to identify benzodiazepines by their 
retention times and by their characteristic ions generated by electron impact (EI) 
ionization.  LC/MS-MS methods have been developed that are very sensitive and utilize 
MS-MS to obtain structural information about the benzodiazepines.  In a study by 
Kronstrand and coworkers [11], hair samples of psychiatric patients were analyzed and 
the calibration range for diazepam, nordiazepam, and oxazepam was 0.125-5 ng/mg of 
hair [2,11].    
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The history of mass spectrometry begins with Sir J. J. Thomson of the Cavendish 
Laboratory of the University of Cambridge, who studied electrical discharges in gases 
and thus led to the discovery of the electron in 1897.  In the early 20th century, Thomson 
went on to construct the first mass spectrometer for the determination of mass-to-charge 
ratios of ions.  In the early stages of mass spectrometry, gases and simple organic 
molecules were analyzed.  More recently, it has been used to study drugs and their 
metabolites, trace chemicals found at crime scenes, and enzymes and other proteins from 
biological matrices [11].  The technology associated with mass spectrometry is constantly 
evolving.  Electron impact (EI) ionization, in which gases are passed through an electron 
beam, was the most common way to ionize compounds of interest (figure 6).  Chemical 
ionization (CI) uses ion-molecule reactions in the gas phase to produce ions from the 
sample molecule.  The process of chemical ionization is initiated with a reagent gas, such 
as methane, isobutane, or ammonia, which is initially ionized by electron impact.  High 
gas pressure in the ionization source results in the propagation of ion-molecule reactions 
between the reagent gas ions and reagent gas neutrals. Some of these ions can react with 
the analyte molecules to produce ions.  Chemical ionization can sometimes offer greater 
sensitivity and for this reason it is commonly used in forensic applications [15,16].  Many 
mass  
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 spectrometers today utilize electrospray where a liquid sample passes through an 
electrically charged nozzle, is nebulized, and then enters a heated capillary on its way to 
the mass detector.  Matrix-assisted laser desorption ionization (MALDI) uses a UV-light 
absorbing matrix mixed with the sample of interest to form a precipitate on a stainless 
steel plate.  A UV-laser is fired at the plate and the sample receives enough energy to 
become ionized, pulled through a vacuum chamber, and is focused electrically until it 
reaches the mass detector.  This technique is used mostly to analyze proteins and other 
biomolecules and is becoming quite common.  Mass spectrometry is used in quantitative 
studies because of its high sensitivity.  A trace amount of a chemical can be detected by 
using an effective method to extract the chemical from its matrix and analyze it with 
mass spectrometry.   For many compounds, there is very good linearity as the 
concentration of the analyte increases.  Standard curves are constructed by adding a fixed 
amount of a standard to increasing concentrations of a compound and plotting the 
relationship on an XY plot.  It is common to see correlation coefficients above 0.995 for 
most analytes in the concentration range of one to 500 nanograms per mL by GC/MS.  
Internal standards are used in analytical chemistry to verify that the instrument and all 
associated parameters are functioning properly and consistently and the ratio of 
concentration/signal response is used along with the signal response of an unknown to 
calculate its concentration.  Stable isotopically-labeled analogs of certain compounds are 
commonly used as internal standards.  GC/MS in mass spectrometric analysis can 
distinguish between two compounds that differ in mass by only one atomic mass unit 
(amu).  With this in mind, analogs of certain compounds are synthesized using deuterium, 
which weighs two amu rather than one amu as is the case for hydrogen, allowing for the 
11 
 detection of the analyte in the presence of internal standard.  The best standards add three 
or more deuterium atoms to the analyte to avoid confusion by the signal for the 13C 
isotopomer and that of the internal standard.  Deuterium labeled analogs have almost the 
same physical properties, such as retention time in gas and liquid chromatography as their 
non-labeled counterparts.  Examples of isotopically labeled internal standards used in 
quantitative GC/MS studies include [13C12]-polychlorinated biphenyls, 14C-arachidonic 
acid, and [6,6-2H2]-ascorbic acid [6,12-14]. 
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 Chapter Two 
Literature Review 
Transdermal Drug Delivery 
Transdermal drug delivery has been well-studied [7].  Numerous compounds have been 
administered successfully by using a transdermal patch in which the drug diffuses 
through the skin.  After a drug passes through the skin, it enters the general circulation for 
a systemic effect.  The first transdermal patch (called the Transderm Scop) was approved 
by the Food and Drug Administration in 1979 for the prevention of nausea and vomiting 
associated with travel, particularly sea-sickness.   
Measuring the effectiveness of a transdermal system can involve detection of the 
drug in blood plasma, measuring excretion of the drug and/or its metabolites in the urine, 
and patient response at some point after administration.  Using transdermal delivery, the 
blood concentration needed to obtain therapeutic efficacy may be determined by 
comparative analysis of patient response to drug blood levels.  It is preferable if the drug 
penetrates through the skin to the underlying blood supply without drug buildup in the 
dermal layers.  The skin is comprised of the stratum corneum (the outer-most layer), the 
living epidermis, and the dermis, which together provide the skin’s protection against 
penetration by external agents (figure 2.1) [7].   
13 
  
 
 
 
The film that covers the stratum corneum is composed of sebum and sweat, and because 
of its varied composition and lack of continuity, it is not a significant factor in drug 
penetration and neither are the hair follicles and sweat and sebaceous gland ducts which 
comprise only a minor proportion of the skin’s surface.   
Percutaneous absorption of a drug usually results from direct penetration of the 
drug through the layer of flat, partially desiccated nonliving tissue.  The stratum corneum 
is composed of roughly 40% protein (mostly keratin) and 40% water, with the remaining 
portion consisting of lipids as triglycerides, free fatty acids, cholesterol, and 
14 
 phospholipids.  Lipid content is concentrated in the extracellular phase of the stratum 
corneum and forms essentially a membrane surrounding the cells.  A major route of drug 
penetration is through the intercellular channels and the lipid component is considered to 
be an important determinant in the first step of drug absorption. 
After passing through the stratum corneum, drug molecules may then pass 
through the deeper epidermal tissues and into the dermis.  When the drug enters the 
vascular dermal layer, it becomes available for absorption into the general circulation.   
Because the stratum corneum is a keratinized tissue, it behaves as a semipermeable 
artificial membrane and drugs penetrate by passive diffusion.  It is considered to be the 
major rate-limiting barrier to transdermal drug transport.  The majority of the body 
contains a stratum corneum that has 15-25 layers of flattened corneocytes with an overall 
thickness of roughly 10 µm.  The rate of drug penetration across this layer depends on the 
concentration of the drug in the delivery system, its aqueous solubility, and the oil/water 
partition coefficient between the stratum corneum and the delivery system.  Drugs that 
possess both lipid and aqueous solubility characteristics are good candidates for diffusion 
through the stratum corneum and the epidermal and dermal layers [7].   
Factors Affecting Transdermal Delivery 
Not every drug can be used effectively in a transdermal delivery system.  Factors such as 
the physical and chemical properties of the drug including molecular weight, solubility, 
partitioning coefficient, pKa, the nature of the carrier-vehicle, and the condition of the 
skin all affect the success of drug delivery.  Generally, the amount of drug absorbed 
increases as the concentration of the drug substance in the delivery system is increased.  
More drug is absorbed when the surface area of application is increased.  The drug should 
15 
 have a greater physicochemical affinity to the skin than to the delivery system in order 
for the drug to leave the system and penetrate into the skin.  Some solubility of the drug 
in lipid and aqueous media is essential for effective absorption.  The aqueous solubility of 
the drug determines the concentration delivered to the absorption site and the partition 
coefficient dictates the rate of transport across the absorption site.  Drugs penetrate 
through the skin best when they are unionized.  Drugs with molecular weights in the 100 
to 800 range and adequate lipid and aqueous solubility can usually permeate skin.  The 
most effective molecular weight for a drug to be used in transdermal delivery is believed 
to be 400 or less [7].    
The Cervix 
The cervix is the narrow, most posterior portion of the uterus.  It is conical in shape, with 
a truncated apex that points downward and backward.  It is about one inch long and 
continuous above with the inferior aspect of the uterine corpus, which is the point of 
juncture known as the isthmus, an area of moderate constriction (figure 2.2). 
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 The vagina is attached obliquely around the center of the cervical periphery, therefore 
dividing the cervix into two sections, the upper or supravaginal portion and a lower 
vaginal portion.  The cervix enters the vagina at an angle through the anterior vaginal 
wall, and normally the vaginal portion is in contact with the posterior vaginal wall [8].  
The supravaginal part of the cervix is separated anteriorly from the bladder by a layer of 
endopelvic fascia.  Laterally, this same level of the cervix is continuous with the 
paracervical ligaments and the uterine blood vessels which they contain (figure 2.3). 
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 Posteriorly, the supravaginal cervix is covered by peritoneum as is reflects off the 
uterosacral ligaments downward toward the apex of the vagina.  The vaginal portion of 
the cervix protrudes into the upper vagina between the upper and lower fornices as a 
convex prominence of somewhat elliptical shape.  A small aperture, which is round or 
slit-like in the nullipara, is central to the protrusion and called the external cervical os.   
This orifice makes the connection between the uterine cavity and the vagina. 
The external os is encircled by the anterior and posterior lips and they are covered with 
stratified squamous epithelium.  The cervical canal extends from the anatomic external os 
to the internal os, where it opens into the uterine cavity.  It is somewhat fusiform or 
spindle-shaped and wider in the middle than at either os.  Anterior and posterior 
longitudinal ridges are evident on the walls of the cervical canal.  They represent lines of 
fusion of the müllerian ducts.  Fanning out laterally from these ridges is a series of folds 
(the plicae palmatae) which resemble branches of a tree trunk.  Some evidence suggests 
the presence of drug transporters in cervical tissue and thus the concept cannot be ruled 
out [8].   
Vaginal Drug Absorption 
Many drugs have been administered through delivery from the vagina.  Miconazole 
nitrate, metronidazole, and other compounds have been delivered in a gel or cream and 
applied to the outer surface and/or inserted into the vagina.   Similar to using a 
transdermal patch, this route of administration avoids first-pass metabolism by the liver.  
However, the localized blood flow of the organ is of a nature that drugs are taken up 
quickly and readily enter systemic distribution [8]. 
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 Quantification of Diazepam by GC/MS 
Measurement of Diazepam in blood plasma using GC/MS has proven to be fast, accurate, 
and repeatable by researchers over the years [2,9,10].  Clinical situations involving 
pharmacokinetic studies, therapeutic monitoring, dosage regimens, and identification of 
compounds with forensic significance have led to the development of several methods for 
quantitation [2].  In a study by Coassolo and coworkers [2], several benzodiazepines were 
extracted from plasma and quantitated by GC/MS (figure 2.4).  The benzodiazepines  
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 were extracted from plasma via a liquid-liquid extraction with butyl acetate at a pH of 
9.0.  The analysis was performed on a compact mass-selective detector operating in the 
electron-impact (EI) mode.  Samples of 1-3 µL were injected into the GC/MS with the 
inlet temperature set at 250 ºC, helium as the carrier gas, and the oven temperature went 
from 70 to 300 ºC at a ramp of 20 ºC per minute.  The compounds were ionized at 70 eV 
when they entered the mass-selective detector.  Identification of the compounds was 
performed by either direct comparison of the observed mass spectra with reference 
spectra or by the relative intensities of the most intense and characteristic ions collected 
in the selected-ion monitoring (SIM) mode.  Certain benzodiazepines were used as 
internal standards for quantitation based on the fact that their retention times were 
significantly different than that of the analyte of interest to avoid co-elution of peaks.  
Intra-assay precision and accuracy were better than 5-6 percent, linearity was satisfactory 
up to 2 µg/mL, and the detection limit was 1-5 ng/mL for most benzodiazepines.  
Diazepam was chosen as the internal standard when measuring flunitrazepam and N-
desmethylflunitrazepam in plasma.  Concentrations of diazepam added ranged from 2.1 
to 21 ng/mL, 3.9 to 39 ng/mL, and 4.2 to 42 ng/mL and their respective correlation 
coefficients were 0.998, 0.990, and 0.998.  The base peak for diazepam was m/z 256, the 
second most intense ion was m/z 283, and the molecular ion (M+.) with m/z of 284 was 
the third most intense ion (figure 2.5) [2]. 
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In another study by Inoue and coworkers [9], several benzodiazepines were extracted 
from whole blood using a solid-phase extraction and quantification was performed by 
GC/MS.  Whole blood was spiked with various benzodiazepines and the extraction was 
performed using an OasisTM HLB solid-phase extraction cartridge that contains a 
copolymer designed to have a hydrophilic-lipophilic balance (figure 2.6).  Nineteen 
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 benzodiazepines and two thienodiazepines were identified using a combination of 
selected ion monitoring (SIM) and total ion chromatograms (TIC) on a GC/MS.  
Calibration curves for the various compounds were constructed using fludiazepam as an 
internal standard and excellent linearity was observed over the concentration range of 5-
500 ng/mL in blood with correlation coefficients greater than 0.995.  The limit of 
detection ranged from 0.2 to 20 ng/mL in blood.  The extraction procedure involved 
adding known concentrations of the compounds in methanol to 1 mL of blood and mixing 
with 4 mL of distilled water.  The mixture was centrifuged and the supernatant was 
mixed with 0.05 M phosphate buffer at pH 7.0. 
OasisTM HLB cartridges were pretreated with methylene chloride, methanol, and 
distilled water and then the sample solution was loaded into the cartridge.  3 mL of 
distilled water was used to wash the cartridge and the compounds were then eluted with 5 
mL of methylene chloride.  The eluates were centrifuged and the remaining aqueous layer 
was discarded and the organic layer was evaporated under nitrogen.  The residues were 
reconstituted in methanol and fludiazepam was added as the internal standard.  2 µL 
samples were injected into the GC/MS with the injection port set at 280 ºC, helium as the 
carrier gas, the oven temperature went from 60 to 300 ºC at 20 ºC per minute, and the 
mass spectrometer was used in electron impact (EI) mode with the ionization energy at  
70 eV [9]. 
Diazepam was quantified and gave the following m/z ions with their respective 
intensities:  256 (100%), 283 (96%), 284 (75%), 221 (44%), and 286 (24%).  The natural 
ratio of 35Cl and 37Cl (a 3:1 ratio) was evident in the 284 and 286 ions.  Linearity of 
diazepam was excellent over the range of 5-500 ng/mL in blood and the correlation 
25 
 coefficient was greater than 0.995.  The limit of detection for diazepam was 1 ng/mL and 
the method proved to be simple and sensitive for measuring benzodiazepines and 
thienodiazepines [9].   
Other Studies Involving Transdermal Delivery to the Cervix 
In a study by Woolfson and coworkers [4], bioadhesive patches containing tritium-
labeled 5-fluorouracil were applied to excised, healthy cervical tissue from hysterectomy 
patients and drug diffusion was measured by liquid scintillation spectrometry (figure 2.7). 
 
 
 
 
26 
 Pre-cancerous dysplastic lesions can often occur in cervical tissue.  The lesions have been 
defined as cervical intraepithelial neoplasia (CIN) and they range from mild (CIN I) to 
severe dysplasia (CIN III).  Cervical intraepithelial dysplasia is initially a noninvasive 
condition and can be identified by smear screening and colposcopy.  When cases of non-
regressing CIN are discovered, treatment usually involves ablative or excisional surgical 
techniques.  Surgery can be very expensive and there is often some resulting damage to 
the structure of the cervix.  Alternative methods to treat CIN are therefore being 
investigated.  It has been shown that lesions can occur not only at the squamocolumnar 
junction, but also in the glandular tissue and cervical crypts.  The depth required for drug 
diffusion in order to reach theses structures is at least 4 mm below the surface of 
application of the cervix.  Patches containing 3.5, 10, and 20 mg of  tritium-labeled 5-
fluorouracil were applied to excised cervical tissue cut into slabs 1 cm2 across the 
epithelial face and approximately 10 mm deep.  The tissue was supported on a stainless 
steel filter grid placed across a reservoir filled with sterile phosphate buffered saline (pH 
7.2) with the volume sufficient to bring the solution up to the grid and expel traces of air.  
The time that the tissue was exposed to the patches was recorded and the tissue was flash-
frozen by exposing it above a liquid nitrogen atmosphere.  The tissue was then cut into 
slices 50 µm thick, added to an appropriate scintillation cocktail, and the amount of drug 
present in the slices determined by liquid scintillation counting.  Patches with different 
concentrations of the drug were applied to the tissue for 4, 8, 12, 18, and 24 hours and as 
expected, the 20 mg patch produced the highest concentrations at the various tissue 
depths.  After the shortest application time of 4 hours, 5-fluorouracil was detected in 
cervical tissue down to a depth of at least 5.5 mm (where it can reach the glandular tissue 
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 and cervical crypts).  For the intermediate time intervals, the maximum diffusion profile 
was observed with little variation at the 8, 12, and 18 hour applications.  The 10 and 20 
mg patches showed similar diffusion patterns with the distribution being linear and 
anomalies observed only in the tissue layers close to the epithelial surface.  It is likely 
that remnants of the patch were collected on the first slice of tissue sample and this led to 
the unusually high concentration observed.  The results indicate that the penetration of 5-
fluorouracil was rapid and extended into the deepest tissue layers.  The drug was detected 
in all reservoirs for the various time periods and all patch doses.  This indicates that drug 
penetration reached a minimum depth of 10 mm below the surface of application.  At the 
critical depth of 5.5 mm, 5-fluorouracil concentrations exceeded 0.25 µg per mg of tissue 
using the 3.5 mg patch concentration.  The 10 mg patch gave a concentration of 
approximately 0.75 µg per mg of tissue and the 20 mg patch gave 1.0 µg per mg of 
tissue.  The concentration observed with the 20 mg patch was roughly 2,000 times in 
excess of the cytotoxic concentration of 5-fluorouracil determined in vitro against HeLa 
cells.  The results suggest that the bioadhesive patch could be effective against malignant 
cells in cervical tissue [4].   
In another study by Woolfson and coworkers [5], a similar approach was 
employed by delivering tritium-labeled 5-fluorouracil to excised cervical tissue via a 
bioadhesive patch.  This study used only the 20 mg patch and quantification was 
performed using autoradiographic imaging.  The patches were applied for 4 and 24-hour 
time periods and the results were similar to the previous study in that the 4-hour 
application was found to be insufficient to achieve high drug concentration throughout 
the upper half of the tissue specimen (5 mm below the epithelial surface).  However, the 
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 24-hour application showed that drug distribution was sufficient to expose potential 
cervical intraepithelial neoplasia (CIN) to cytotoxic levels of 5-fluorouracil.  The 
autoradiographs showed evidence of areas of locally high drug concentration which could 
be aqueous-filled pores that are known to be present in the cervix.  5-Fluorouracil is 
relatively water soluble and thus diffusion through aqueous pores could have a significant 
role in drug diffusion through the cervix.   
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 Chapter Three 
Materials and Methods 
Materials 
Diazepam was purchased from Sigma Chemical Company (St. Louis, MO).  Deuterated 
2H5 -diazepam was purchased from Cambridge Isotope Laboratories (Andover, MA).    
KY JellyTM was obtained locally.  Diazepam (5mg/5g) was formulated in KY JellyTM by 
the Pharmacy Department of Ruby Hospital, Morgantown, WV and stored under 
refrigeration.  Absolute ethanol was purchased from Mallinckrodt Baker (Paris, 
Kentucky).  All other chemicals were obtained from Aldrich Chemical Company 
(Milwaukee, WI) and were of the highest purity available.   
Patient Information 
No personal information about the subjects that volunteered for the study was collected at 
any time.  The patients were referred to by the letter D and numbers one through 19 
(D1-D19). 
Preparation of Solutions 
Stock solutions of diazepam and 2H5 -diazepam were prepared by dissolving accurately 
weighed 10.0 mg in 10.0 mL of reagent grade methanol.  Subsequent dilutions of 1, 10, 
40, 100, 250, and 500 ng/mL in methanol were made and standard curves were 
constructed using 40 µL of 2H5 -diazepam (1 µg/mL in methanol) added to the various 
concentrations of diazepam.  Control samples of blank plasma were obtained from a local 
hospital and found to be drug free before use. 
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 Methods 
Patients undergoing hysterectomy were anesthetized and 5 mg of diazepam in 5 g of gel 
was administered using the CerviPrepTM device.  The operation was then begun and 
blood samples were taken from a peripheral vein at 0, 5, 10, 15, and 30 minutes during 
drug administration.  Samples were also taken from the uterine vein and uterine capillary 
bed at 30-45 minutes during drug administration.  Blood samples were processed to 
separate red blood cells from plasma.  The plasma sample (1 mL) was taken and 40 µL of 
2H5 -diazepam (1 µg/mL in methanol) was added and vortexed for one minute. Sodium 
hydroxide (20 µL, 2N) was added to adjust the pH of the sample to about 9 and 3 mL of 
ethyl acetate were added and vortexed for one minute.  Samples were then placed in a 
DynacTM centrifuge at 10,000 rpm for 5 minutes and the ethyl acetate layer was removed 
by micropipette.  The liquid was then evaporated in a 15 mL test tube on a heat block at 
80 ºC under a gentle stream of nitrogen.  The residues were reconstituted with 40 µL of 
ethanol, placed in National ScientificTM GC/MS auto sampler vials, and 2 µL was 
injected into the GC/MS (schematic 3.0). 
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 The method adapted from a validated method by Choi [10] and the limit of detection for 
diazepam was 0.5 ng/mL, the assay was sensitive to 1 ng/mL and linear to 500 ng/mL 
with a correlation coefficient of 0.997, and the recovery was 93.4 percent. 
Instrumentation 
The samples were analyzed by an Agilent MSD 5973 gas chromatograph/mass 
spectrometer.  The column was a DB-5MS capillary column (30m x 0.25mm x 0.2µm) 
and ultra high purity helium was used as the carrier gas at a flow rate of 1 mL per minute.  
The injection port temperature was set at 280 ºC and the inlet was operated in the splitless 
mode (with a 0.75 minute purge delay).  The oven temperature was held at 180 ºC for one 
minute and ramped at 20 ºC per minute to a temperature of 280 ºC and held for 14 
minutes.  The MSD transfer line was set at 280 ºC.  The mass spectrometer was used in 
electron impact (EI) mode at 70eV and operated in selected ion monitoring (SIM) mode 
to observe m/z 283 for diazepam and 287 for 2H5 [phenyl]-diazepam.   
Data Analysis 
Standard curves were constructed on each day of analysis using 40 µL of  2H5 -diazepam 
(1 µg/mL in methanol) and the amounts of diazepam listed previously.  For the plasma 
samples, chromatographic peaks were integrated by the software and the ratio of 40 ng of 
2H5 -diazepam divided by its area and the area observed for the unknown amount of 
diazepam were used to calculate the ng/mL of diazepam in plasma. 
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 Preliminary Studies 
In the early stages of the study, the method of blood sampling involved taking samples 
from the uterine vein, uterine capillary, and peripheral blood at one and five minutes post 
administration.  The procedure was not performed consistently for patients D1-D5.  The 
method then changed to include sampling of peripheral blood at 0, 5, 10, 15, and 30 
minutes during administration and sampling of the uterine vein and capillary blood at 30-
45 minutes during drug administration.  This methodology was used for patients D6 
through D19. 
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 Chapter Four 
Results 
Standard curves were constructed for each analysis and consisted of adding 40 µL of  2H5 
-diazepam (1 µg/mL in methanol) to concentrations of 1, 10, 40, 100, 250, and 500 
ng/mL of diazepam in methanol (figure 4.0).   
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 The quantification performed using the GC/MS was done in a routine manner using the 
same procedure for every sample.  The method used for quantifying diazepam was 
validated, the limit of detection was 0.5 ng/mL, the assay was sensitive to 1.0 ng/mL and 
linear up to 500 ng/mL, and the correlation coefficient was 0.997.  The 2H5 -diazepam 
internal standard consistently eluted just before diazepam and always gave similar peak 
areas and ion counts at 40 ng/mL (figures 4.1, 4.2).  The ion monitored for 2H5 –
diazepam was m/z 287 and this resulted from the loss of one deuterium atom (similar to 
how diazepam lost one hydrogen atom to give m/z 283).   
 
 
 
Figure 4.1 Chromatogram and mass spectrum of 2H5 –diazepam. 
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Figure 4.2 Chromatogram and mass spectrum of diazepam. 
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 The manufacturer of the 2H5 -diazepam claimed that the isotopic purity was 98%.  After 
obtaining an electrospray spectrum, it was concluded that the claim could be 
substantiated (figure 4.3). 
 
 
 
 
 
 
Figure 4.3 An ESI spectrum of 2H5 -diazepam showing the isotopic purity. 
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 For some of the patients, circumstances encountered during the surgical procedure 
prevented the collection of data at the predetermined time intervals.  In a couple of cases, 
the method of sampling did not work well and no diazepam was found in the plasma 
samples.  The graphs that follow are for patients D6 through D19.  D14 data were omitted 
because no diazepam was found in the plasma sample. 
The peripheral blood samples from patient D6 shows the concentration of 
diazepam increasing over time, supporting the conclusion that diazepam was absorbed 
through the cervix and then entered the general circulation.  At 30 minutes during drug 
administration, the peripheral blood concentration was 27.2 ng/mL, the uterine vein was 
238.7 ng/mL, the uterine capillary was 24.1 ng/mL and thus the concentration found in 
the uterine vein was almost ten-fold greater than that found in the peripheral blood (figure 
4.5, 4.6). 
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 The peripheral blood samples from patient D7 increased over time with the exception of 
the 30-minute sample which was slightly less than the 15-minute sample.  The uterine 
capillary blood sample at 30 minutes was roughly two-fold greater in diazepam 
concentration than the peripheral blood sample with the highest concentration (40.7 
ng/mL versus 19.5 ng/mL). 
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 The concentration of diazepam increased over time in the peripheral blood of patient D8 
with the exception of the 30-minute sample.  The highest concentration found in 
peripheral blood was 15.2 ng/mL and the concentrations found in the uterine vein and 
capillary blood were 434.2 ng/mL and 221.4 ng/mL, respectively.  The uterine vein 
concentration was roughly 29 times greater and the capillary blood was roughly 15 times 
greater than the highest amount found in peripheral blood (15.2 ng/mL). 
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 The concentration of diazepam increased over time in the peripheral blood of patient D9 
to a maximum of 17.5 ng/mL at 30 minutes.  The concentration found in the uterine 
capillary blood was 22.4 ng/mL and in the uterine vein was 17.9 ng/mL.   
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 The concentration of diazepam increased over time in the peripheral blood of patient D10 
to a maximum of 5.1 ng/mL at 30 minutes.  The uterine capillary blood at 30 minutes had 
a concentration of 28.8 ng/mL and this is roughly 6 times greater than the highest found 
in peripheral blood.  The uterine vein had a concentration of 6.2 ng/mL, which is slightly 
greater than that found in the peripheral blood at 30 minutes. 
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 The concentration of diazepam steadily increased over time in the peripheral blood of 
patient D11 to a maximum of 4.4 ng/mL.  The uterine vein had a concentration of 507.1 
ng/mL at 30 minutes and the uterine capillary blood had 214.1 ng/mL at 30 minutes and 
these values are roughly 115 and 49 times greater than the highest found in peripheral 
blood, respectively. 
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 The values for peripheral blood increased over time for patient D12 with the exception of 
the sample taken at 15 minutes.  The highest concentration found in peripheral blood was 
8.5 ng/mL at 30 minutes.  The uterine vein had 13.3 ng/mL and the uterine capillary 
blood had 24.4 ng/mL and these values are roughly 2 and 3 times greater, respectively. 
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 The diazepam levels at 0 and 5 minutes were below the detection limit for patient D13.  
The concentration increased over the last three sampling times to a maximum of 5.1 
ng/mL.  The uterine capillary blood had a concentration of 6.0 ng/mL at 30 minutes, 
which is slightly greater than the amount found in peripheral blood.  The uterine vein had 
4.7 ng/mL, slightly less than the amount found in peripheral blood. 
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 Diazepam was detected only at the 30-minute sampling time for peripheral blood in 
patient D15 and the value was 6.1 ng/mL.  The uterine vein had 14.5 ng/mL and the 
uterine capillary blood had 58.5 ng/mL and these values are roughly 2 and 10 times 
greater than the peripheral blood value, respectively. 
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 Diazepam was detected only at the 15-minute sampling time in patient D16 with a value 
of  2.4 ng/mL.  The uterine vein had 158.6 ng/mL and the uterine capillary blood had 
14.5 ng/mL and these values are roughly 66 and 6 times greater than the highest found in 
peripheral blood, respectively. 
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 No diazepam was found in the peripheral blood of patient D17.  The uterine vein had 7.9 
ng/mL and the uterine capillary blood had 4.6 ng/mL. 
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 The concentration of diazepam in peripheral blood increased over time in patient D18 to 
a maximum of 11.4 ng/mL.  The uterine vein had 7.4 ng/mL and the uterine capillary 
blood had 44.0 ng/mL.  The uterine vein had slightly less and the uterine capillary blood 
had roughly 4 times the concentration of the highest found in peripheral blood. 
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 The highest concentration of diazepam in the peripheral blood of patient D19 was 5.1 
ng/mL and was found at 30 minutes.  The uterine vein had 17.6 ng/mL and the uterine 
capillary blood had 63.1 ng/mL and these values are roughly 3 and 12 times greater than 
the highest found in peripheral blood, respectively. 
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 Chapter Five 
Discussion 
In concurrence with data by Woolfson and coworkers [4,5], it appears that it is possible 
for a drug to be absorbed when applied directly to the cervix.  The following patients had 
a higher concentration of diazepam in either the uterine vein or uterine capillary blood 
sample, or both when compared to the highest concentration found in peripheral blood:  
D6, D7, D8, D9, D10, D11, D12, D13, D15, D16, D18, and D19.  Three of the patients 
had very high concentrations of diazepam in the uterine blood with relatively low 
amounts found in the peripheral blood.  Patient D6 had 238.7 ng/mL in the uterine vein 
sample, 24.1 ng/mL in the uterine capillary blood sample, and 27.2 ng/mL in the 
peripheral sample with the highest concentration.  Patient D8 had 434.2 ng/mL in the 
uterine vein sample, 221.4 ng/mL in the uterine capillary blood sample, and 15.2 ng/mL 
in the peripheral sample with the highest concentration.  Patient D11 had 507.1 ng/mL in 
the uterine vein sample, 214.1 ng/mL in the uterine capillary blood sample, and 4.4 
ng/mL in the peripheral sample with the highest concentration.  It is unclear why these 
three patients had substantially higher concentrations in uterine blood when compared to 
the rest of the subjects.  Patient D13 had uterine blood concentrations of 4.7 and 6.0 
ng/mL and the highest peripheral blood concentration was 5.1 ng/mL.  The active 
metabolite of diazepam (nordiazepam) was not detected in any of the samples tested.  A 
statistical t-test was calculated and the results showed that the concentration of diazepam 
was higher in uterine blood than in peripheral blood at the 95 percent confidence level.  
The doctors performing the surgery indicated that circumstances involved with the 
surgery sometimes interfered with taking blood samples at the predetermined times and it 
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 would be beneficial to have more trials to streamline the techniques.  It is unclear whether 
or not the placement of the delivery device was precise enough to be in close contact with 
the cervix for the duration of drug delivery.  No patient history was incorporated into the 
study.  Patients may have had previous surgery on the cervix and the presence of scar 
tissue would affect drug absorption.  The weight of the patient could also have an impact 
on drug absorption because of its lipophilic nature. 
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 Chapter Six 
Conclusion 
A sensitive, specific quantitative assay for diazepam was developed based on gas 
chromatography/mass spectrometry.  Stable isotope labeled diazepam was used as an 
internal standard.  The current studies support the concept of cervical absorption of drugs.  
Subsequent uptake by uterine tissue was also observed.  The study showed that the cervix 
could absorb a drug when directly applied to its surface and higher concentrations are 
found in uterine blood than peripheral blood suggesting tissue selectivity 30 minutes 
during application.  Some of the patients had very high concentrations in the uterine 
blood samples.  This means it may be possible to deliver other drugs in a similar manner 
and observe high blood concentrations only where it is desired (the uterus).  Further 
studies using anti-cancer drugs and drugs used to treat other cervical and uterine diseases 
should be considered. 
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